Vaccination or prior encounter with a microbe generally results in immunity to subsequent infection with that microbe. This immunity is mediated by memory T cells and B cells, which are generated from naive precursor cells after exposure to microbial antigens. Binding of the T cell antigen receptor (TCR) to microbe-derived peptide bound to major histocompatibility complex molecules (pMHC) causes naive T cells to proliferate and to differentiate into effector cells able to produce microbicidal cytokines 1 . Although ~90% of the effector cells die, some survive to become long-lived memory cells capable of a rapid and protective response to reinfection with the relevant microbe 2 .
Two main subsets of memory T cells have been described: central memory T cells (T CM cells) and effector memory T cells (T EM cells) [3] [4] [5] . T CM cells express the chemokine receptor CCR7 (A000630) and L-selectin, which allows recirculation through lymph nodes. T EM cells lack CCR7 and L-selectin yet express other homing receptors needed for migration into nonlymphoid organs 6 . When stimulated with antigen, T EM cells are immediately capable of effector cytokine production and cytolysis, whereas T CM cells proliferate to produce new effector cells, which then acquire these functions. Heterogeneity in lymphokine production potential also exists in the case of CD4 + T cells. Naive CD4 + T cells differentiate into T helper type 1 (T H 1), T H 2 or interleukin 17 (IL-17)-producing T helper (T H 17) effector cells when stimulated in vitro with antigen and specific combinations of cytokines 7 . In addition, certain infections induce CD4 + effector cells with the properties of T H 1 or T H 2 cells 8 .
However, it is still not clear that CD4 + memory T cells specific for peptide-MHC class II (pMHCII) exist as discrete T H 1, T H 2 or T H 17 subsets in vivo because such cells are difficult to detect in normal hosts. To circumvent this problem, researchers have studied immune memory by CD4 + T cells in vitro 9 , or in vivo 1, 10, 11 by adoptive transfer of TCR-transgenic T cells. These approaches are artificial in that memory T cells are generated from disrupted lymphoid tissue [9] [10] [11] or are so abundant that normal homeostasis is perturbed [12] [13] [14] . Thus, it is not clear how well polyclonal CD4 + memory T cells fit into the T H 1, T H 2, T H 17 or T CM and T EM categories.
Here we addressed this problem with a sensitive pMHCII tetramerbased approach that allowed detection of polyclonal pMHCIIspecific CD4 + T cells in normal mice after infection with Listeria monocytogenes. We found that intravenous and intranasal infection induced T H 1 and T H 17 CD4 + effector T cells, respectively, although the most abundant cells in both cases did not resemble any of the canonical helper T cell subsets. In addition, we found that T H 1 cells were much more likely than T H 17 cells to enter the memory cell pool.
RESULTS

Detection of pMHCII-specific CD4 + memory T cells
We used a pMHCII tetramer-based approach to identify CD4 + T cells specific for a pMHCII complex produced during bacterial infection. The pMHCII tetramer consisted of the I-A b MHC class II molecule bound to a variant of amino acids 52-68 from the I-E α-chain called 2W1S (2W1S:I-A b ) 15 . The 2W1S peptide is highly immunogenic in C57BL/6 (B6) mice because of a relatively large naive population able to recognize 2W1S:I-A b (ref. 16 ). We infected B6 mice with an attenuated strain of L. monocytogenes (∆ActA) engineered to secrete a fusion protein containing a portion of chicken ovalbumin and the 2W1S peptide (LM-2W1S) 17 or the mycobacterial peptide ESAT6 (LM-ESAT6) 18 . These bacteria replicate for several days in mice and are then completely eliminated by innate and adaptive 19 . We stained cells from each mouse with a fluorochrome-labeled 2W1S:I-A b tetramer and anti-fluorochrome magnetic beads at various times after infection and enriched them on a magnetized column 20 . We then stained the bound fraction with antibodies specific for CD3, CD4, CD8 and CD44 and a 'cocktail' of non-T cell lineage-specific antibodies to aid in the identification of CD4 + memory T cells.
Because effector and memory T cells express many of the same surface markers, we identified the latter cells as the population that stabilized after the expansion and contraction phases of the primary response 21 . Our initial analyses involved standard intravenous infection. Mice that were not infected contained a small population of about 300 2W1S:I-A b -binding CD3 + CD4 + cells in the spleen and lymph nodes, the vast majority of which were CD44 lo , as expected for naive cells (Fig. 1a) . The tetramer bound to these T cells via the TCR, as shown by the finding that we detected no 2W1S:I-A b -binding cells among the CD8 + MHC class I-restricted T cells. Mice infected 7 d earlier with LM-ESAT6 also contained about 300 CD44 lo 2W1S: I-A b+ CD4 + naive T cells (Fig. 1b) . In contrast, mice infected with LM-2W1S 7 d earlier contained a large population of CD44 hi 2W1S: I-A b+ CD4 + T cells in the spleen and lymph nodes that could still be detected on day 190 and beyond. The number of 2W1S:I-A bspecific CD4 + T cells peaked at ~140,000 cells by day 5 after LM-2W1S infection and then decreased rapidly to 20,000 cells by day 20 (Fig. 2 ). This contraction phase ended abruptly on day 20, after which the population slowly decreased until day 250, with a half-life of about 40 d (Fig. 2) . By day 250, only about 200 CD44 hi 2W1S:I-A b+ CD4 + T cells remained in the spleen and lymph nodes, and this number remained stable for the next 150 d. Although we did not detect 2W1S:
I-A b+ CD4 + T cells in the bone marrow in uninfected mice (data not shown), about 1,500 CD44 hi 2W1S:I-A b+ CD4 + T cells appeared in the bone marrow by day 20 and then decreased to 150 cells by day 300. Thus, 2W1S:I-A b -specific CD4 + T cell populations expanded to a peak number on day 5, contracted until day 20, and then entered a memory phase characterized by slow numerical decrease for the next 230 d. In addition, some of the 2W1S:I-A b -specific memory CD4 + T cells were present in the bone marrow, although more were present in the spleen and lymph nodes.
Infection route influences CD4 + T cell differentiation
We next determined whether CD4 + memory cells induced by intravenous infection resembled any of the canonical helper T cell subsets. We measured lymphokine production by 2W1S:I-A b -specific CD4 + memory cells by direct ex vivo intracellular staining 22 in mice that were infected 24 d before with LM-2W1S and then challenged for 2 h with LM-2W1S or LM-ESAT6. We chose 2 h because this is the time of maximal in vivo lymphokine production by antigen-experienced CD4 + T cells stimulated by intravenous injection of peptide 23 or infection with LM-2W1S (data not shown). We found that 2W1S:I-A b -specific CD4 + memory cells did not express CD69 (Fig. 3a) or produce interferon-γ (IFN-γ) or IL-17A after challenge with LM-ESAT6 (Fig. 3a,b) . In contrast, about 30-40% of the memory cells produced IFN-γ after challenge with LM-2W1S (Fig. 3a,b) , whereas none of these cells produced IL-17A (Fig. 3b) or IL-5 (data not shown). The failure of the majority of 2W1S:I-A b -specific CD4 + memory cells to make IFN-γ after challenge was not related solely to a lack of 2W1S:I-A b recognition after challenge, as many of the cells expressed the TCR signal-dependent CD69 molecule but did not make IFN-γ (Fig. 3a) . Therefore, about one third of the 2W1S:I-A b -specific CD4 + memory cells induced by intravenous infection resembled T H 1 cells, whereas the remainder did not produce any of the canonical T H 1, T H 2 or T H 17 cytokines.
It was possible that many of the 2W1S:I-A b -specific CD4 + memory cells that were CD69 + but were not making cytokines 2 h after challenge would have gone on to produce cytokines. To address this issue, we stimulated spleen and lymph node cells from mice infected 22 d earlier with LM-2W1S in vitro with the soluble TCR signal mimics phorbol 12-myristate 13-acetate and ionomycin in the presence of an exocytosis inhibitor. IFN-γ-producing cells peaked at about 50% of the total 2W1S:I-A b -specific CD4 + memory population between 3.5 and 6 h of stimulation (Fig. 3c) . As IFN-γ should accumulate in these conditions, these results indicated that only a subset of the 2W1S:I-A b -specific CD4 + memory cell population had the potential to produce IFN-γ. This conclusion was supported by the finding that about 50% of the 2W1S:I-A b -specific CD4 + memory cells induced by intravenous infection expressed the T H 1-associated transcription factor T-bet 24 before challenge, whereas none expressed the T H 17-associated transcription factor RORγt 25 ( Fig. 3d) and none became Foxp3 + regulatory T cells 17 . As T-bet expression controls the T H 1 differentiation program in most cases 24 , this finding indicated that only a subset of the memory cells induced by intravenous infection had differentiated into T H 1 cells.
One factor potentially driving the induction of T H 1 but not that of T H 17 or T H 2 cells was the intravenous route of infection. We therefore studied the effect of intranasal administration of LM-2W1S based on reports that IL-17A-producing T cells are induced during mucosal bacterial infection 26, 27 . Indeed, we found that about 7% of the 2W1S: I-A b -specific CD4 + T cells in the spleen and lymph nodes of mice 24 d after intranasal infection with LM-2W1S produced IL-17A, whereas very few produced IFN-γ, 2 h after challenge with LM-2W1S but not after challenge with LM-ESAT6 (Fig. 3b) . In addition, about 15% of the 2W1S:I-A b -specific T cells induced by intranasal infection expressed RORγt, as shown by the expression of green fluorescent protein in mice heterozygous for expression of green fluorescent proteintagged RORγt and by intracellular staining for RORγt (Fig. 3d) . These results demonstrate that intranasal infection with LM-2W1S induced some of the 2W1S:I-A b -specific T cells to differentiate into T H 17 cells. However, as with intravenous infection, the main population showed no evidence of committing to either a T H 1 or T H 17 canonical lineage.
T H 17 cells are shorter-lived than T H 1 cells
We next measured the survival of IFN-γ-or IL-17A-producing T cells to determine if these subsets were equally efficient at entering the memory pool. We infected mice and then challenged them later at various times with an intravenous injection of LM-2W1S to identify the lymphokine-producing cells. Intravenous infection with LM-2W1S generated about 12,000 IFN-γ-producing 2W1S:I-A b -specific effector T cells in the spleen and lymph nodes by day 7, which constituted about 10% of all 2W1S:I-A b -specific T cells. At all times after the contraction phase, IFN-γ-producing cells accounted for about 25% of the 2W1S:I-A b -specific memory cells (Fig. 4a) . Therefore, IFN-γ-producing 2W1S:I-A b -specific T cells were as good as or better than non-IFN-γ-producing cells at entering the memory pool.
Intranasal infection induced a pattern of 2W1S:I-A b -specific CD4 + T cell population expansion, contraction and memory cell formation similar to that induced by intravenous infection, albeit to a lower extent (Fig. 4b) . The lower magnitude of this response was probably related to the fact that the nasal mucosal lymphoid tissues, which are the main sites of priming after intranasal infection 28 , contain many fewer naive T cells than does the spleen, where priming occurs after intravenous infection. About 2,000 IL-17A-producing 2W1S: I-A b -specific effector cells were present on day 7, which, as for IFN-γ-producing cells in intravenously infected mice, constituted about 10% of all 2W1S:I-A b -specific T cells at this time. However, unlike IFN-γ-producing cells, IL-17A-producing 2W1S:I-A b -specific cells were progressively lost, such that fewer than 10 cells (or 0.5% of all 2W1S:I-A b -specific T cells) remained at day 110 after infection. Thus, IL-17A-producing cells did not enter the memory pool as efficiently as IFN-γ-producing cells did. Published work has demonstrated that CD8 + memory T cells can be categorized on the basis of expression of the tumor necrosis factor receptor family member CD27 (A000546) 29, 30 . In addition, CD8 + memory cells that lack expression of CD27 have been shown to be short-lived [30] [31] [32] [33] . Therefore, we assessed expression of CD27 and CCR7, a marker used to distinguish T CM cells from T EM cells 3 . Most of the IFN-γ + or T-bet + 2W1S:I-A b -specific CD4 + T cells present more than 20 d after intravenous infection were CCR7 lo CD27 + (Fig. 5a,b) . Although cells with this phenotype were also present among the IFN-γ -or T-bet -cells in the same mice, these populations also contained many CCR7 hi CD27 + and CCR7 hi CD27 -cells. In contrast, most of the IL-17A + 2W1S:I-A b -specific CD4 + T cells present after intranasal infection were CCR7 hi CD27 - (Fig. 5c) , whereas the IL-17A -cells included more CCR7 hi CD27 + and CCR7 hi CD27 -cells like the IFN-γ -cells in intravenously infected mice. Although the RORγt + 2W1S:I-A b -specific CD4 + T cells included CCR7 hi CD27 -cells, as in the case of IL-17A-producing cells (Fig. 5d) , the RORγt + populations also contained CD27 + cells. Therefore, on the basis of CCR7 expression, the T H 1 cells resembled T EM cells, whereas the T H 17 cells resembled T CM cells.
The finding that IL-17A-producing CD4 + T cells lacked CD27 and were short-lived motivated us to explore whether all CD27 -CD4 + memory cells had this property. We tested this possibility in an adoptive-transfer experiment involving total CD4 + memory T cells, as 2W1S:I-A b -specific memory cells were too infrequent to detect reliably after transfer. We sorted purified total CD27 + or CD27 -CD4 + CD44 + T cells from L. monocytogenes-infected B6 mice (CD90.2 + ) and transferred them into naive B6.PL-Thy-1 a (CD90.1 + ) recipients (Fig. 6a) . The CD27 + CD4 + memory cells survived stably over a 14-day period after adoptive transfer, whereas the number of purified CD27 -CD4 + memory cells decreased by about 80% (Fig. 6b) . Thus, CD27 -CD4 + memory T cells were short-lived compared with CD27 + CD4 + memory T cells. Although this observation was based on total CD4 + memory cells, it correlated with the finding that a subset of CD27 + 2W1S:I-A b -specific CD4 + memory T cells expressed more of the survival protein Bcl-2 than did CD27 -memory T cells of the same specificity (Fig. 6c) .
Minimal homeostatic proliferation by CD27 -CD4 + T cells
It was also possible that poor homeostatic proliferation contributed to the short lifespan of CD27 -CD4 + memory T cells. We tested this possibility with a bromo-2-deoxyuridine (BrdU)-labeling experiment. We infected B6 mice with LM-2W1S and, 40 d later, gave the mice BrdU in their drinking water for 2 weeks. About 10% of the 2W1S:I-A bspecific CD4 + memory T cells induced by intravenous or intranasal infection labeled with BrdU ( Fig. 7a and data not shown) . Among the 2W1S:I-A b -specific CD4 + memory T cells, about 15% of the CD27 + cells and only 3% of the CD27 -cells labeled with BrdU (Fig. 7a,b) . The homeostatic proliferation results correlated with expression of the β-chain of the IL-15 receptor (IL-15R; also known as CD122). CD122 was expressed on some CD27 + CD4 + memory T cells but very few CD27 -CD4 + memory T cells (Fig. 7c) . Together, these results showed that CD27 -CD4 + memory T cells were poor homeostatic proliferators, perhaps as a result of a lack of IL-15R expression.
To further test that hypothesis, we injected mice with IL-15-IL-15Rα complexes, which have been shown to be superagonists for IL-15R signaling in vivo 34 . Injection of IL-15-IL-15Rα complexes into B6 mice 40 d after intravenous infection with LM-2W1S led to an increase of ~30-fold in the fraction of 2W1S:I-A b -specific CD4 + memory cells that underwent homeostatic proliferation over a short 5-day BrdU-labeling period, and the populations that proliferated were enriched for CD27 + cells (Fig. 7d) . These results 
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indicate that a lack of IL-15R expression limits the homeostatic proliferation of CD27 -CD4 + memory T cells.
DISCUSSION
Here we found that intravenous or intranasal infection with LM-2W1S induced polyclonal 2W1S:I-A b -specific CD4 + memory T cells. The emergence of memory-phenotype cells was preceded by robust proliferation of naive cells, which peaked in the secondary lymphoid organs about a week after infection. In both infections, the number of 2W1S:I-A b -specific CD4 + T cells decreased rapidly after the peak. This contraction phase ended on day 20, after which the number of cells decreased slowly. The abrupt change in survival observed at day 20 indicated that this is when the memory phase of this response begins. Most of the 2W1S:I-A b -specific CD4 + T cells induced by intravenous infection were in the secondary lymphoid organs during the memory phase, with considerably fewer cells in the bone marrow. Thus, the secondary lymphoid organs are the main reservoir of endogenous polyclonal CD4 + memory T cells induced by intravenous bacterial infection and the bone marrow is not, as described for TCR-transgenic memory cells induced by immunization with peptide plus adjuvant 35 . Our results suggest that some but not all aspects of the T H 1-or-T H 17 and T EM -or-T CM paradigms apply to all CD4 + memory T cells. The IFN-γ-producing memory cells induced by the transient bacterial infection studied here resembled T H 1 and T EM cells because of their immediate ability to produce IFN-γ but not IL-17A and lack of CCR7 expression 3 . Similarly, the IL-17A-producing cells induced by intranasal infection resembled T H 17 and T EM cells because of their immediate ability to produce IL-17A but not IFN-γ. However, these cells expressed CCR7 and thus were phenotypically similar to T CM cells and were short-lived. In addition, the dominant population of memory cells induced by either infection route did not produce IFN-γ, IL-17A or IL-5 and was heterogeneous in terms of expression of CCR7 and CD27. Therefore, these cells did not fit easily into the T H 1, T H 2 and T H 17 paradigm or T CM and T EM paradigm. These cells may be less differentiated and thus able to become T H 1, T H 2 or T H 17 cells after secondary infection. Alternatively, these cells could be highly differentiated cells that produce lymphokines other than those that define the classical subsets.
The tendency of different routes of infection to induce different memory cells may be related to the innate cytokine environments of the relevant secondary lymphoid organs. Anatomic constraints make it likely that naive CD4 + T cells first become activated in the nasalassociated mucosal lymphoid tissue after intranasal infection 28 . A published study has found that IL-17A-producing CD4 + effector T cells are 'preferentially' induced in mice exposed to Francisella tularensis organisms via the respiratory mucosa 26 . Similarly, another study has shown that infection of the upper airway with Streptococcus pneumoniae organisms generates a population of IL-17A-producing CD4 + T cells 27 . Thus, it is possible that the environment in mucosal secondary lymphoid organs is especially conducive to the differentiation of IL-17A-producing T cells. As IL-6 is required for the differentiation of these cells 36, 37 , it is noteworthy that dendritic cells from the intestinal mucosal tissue have been reported to be better IL-6 producers than are splenic dendritic cells 38 . In addition, transforming growth factor-β, which is also essential for the differentiation of IL-17A-producing T cells, is abundant in the mucosal tissues 39 . Conversely, splenic dendritic cells are potent producers of IL-12 (ref. 40) , which is required for the differentiation of IFN-γ-producing T cells 41 .
Our results confirm the idea that the number of CD4 + memory T cells decreases slowly over time, at least in some cases. Published work has reported this finding for IFN-γ-producing CD4 + memory T cells induced by infection with lymphocytic choriomeningitis virus 42 . We also found that the total population of 2W1S:I-A b -specific CD4 + memory T cells induced by intravenous bacterial infection, including those with IFN-γ-production potential, decreased slowly, with a halflife of about 40 d, between days 20 and 250 of the memory phase. It is worth noting that the aforementioned viral infection 42 and the bacterial infections studied here were cleared very quickly from the host. Thus, the decrease in the number of CD4 + memory T cells described in both cases may be related to a lack of persistent antigen presentation. It will be of interest to determine if the number of CD4 + memory T cells also decreases during persistent infection caused by organisms such as Salmonella enterica serovar Typhimurium 43 .
After day 250, the number of 2W1S:I-A b -specific memory cells stabilized at a number only about twice the number of naive cells. This survival pattern was similar to that observed for polyclonal naive The decrease in the number of CD4 + memory T cells induced by transient infection is in contrast to the considerable numerical stability of CD8 + memory T cells 42 . As IL-15 is important for the homeostatic proliferation of both types of memory cells 44 , it may be telling that most CD4 + memory T cells induced by bacterial infection, especially those lacking CD27, did not express IL-15R. It is therefore reasonable to suspect that a low rate of IL-15-driven homeostatic proliferation contributed to the numerical decrease in CD4 + memory T cell populations observed in our experiments. Our finding that increasing the availability of IL-15 in the form of IL-15-IL-15Rα complexes increased the homeostatic proliferation of CD4 + memory T cells is consistent with this possibility.
IL-17A-producing effector cells did not efficiently enter the memory cell pool. One possible explanation for this finding is that these cells simply lost the ability to produce IL-17A 37 . Alternatively, the IL-17A-producing cells could have died because of a lack of CD27. CD27-CD70 interactions have been shown to be important for the maintenance of CD8 + memory cells 31, 45 , perhaps via CD27 signaling through the adaptor TRAF5 (ref. 46) . The lack of a CD27 signal may have also lead to lower expression of the antiapoptotic protein Bcl-2 and a greater rate of apoptosis than that of CD27 + CD4 + memory cells. In contrast, IFN-γ-producing memory cells may gain a survival benefit from the expression of T-bet, which has been reported to control CD122 expression and thus the capacity for IL-15-dependent homeostatic proliferation 47 . Challenging this scenario is the finding that T-bet expression is a marker of terminal differentiation and death in CD8 + memory T cells 48 .
Our results also demonstrated an association between CD27 expression and lymphokine-production potential. This finding adds to other evidence indicating that signaling through CD27 is causally related to the acquisition of IFN-γ-production potential 49, 50 , perhaps by contributing to the induction of T-bet 51 . However, it is worth noting that about half of the RORγt + 2W1S:I-A b -specific memory cells induced by intranasal infection expressed CD27 but did not produce IFN-γ or IL-17A and could have been committed to the production of IL-22 or IL-17F 52 . Thus, CD27 may be necessary but not sufficient for IFN-γ production by CD4 + memory cells and may be not permissive for IL-17A production. This possibility is supported by work indicating that CD27 + γδ T cells cannot become IL-17-producing cells 53 .
Finally, our results have implications for protective immunity. Intranasal immunization of mice with S. pneumoniae induces protective immunity that is dependent on IL-17A and CD4 + T cells 54 . Our findings suggest that this immunity may be short-lived, because IL-17A-producing CD4 + effector T cells do not survive to become memory cells. In support of this suggestion is the clinical observation that streptococcal infections such as otitis media tend to recur 55 .
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
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